In a remarkable medical advancement, baby KJ Muldoon received a groundbreaking personalized medicine. This CRISPR cas9 gene therapy targets CPS1 deficiency, a rare disease. This innovative treatment offers new hope for infant health, showcasing how precision medicine can address severe genetic disorders.
Chapters
00:00 - Personalized CRISPR Breakthrough
01:44 - Gene Therapy vs. Traditional Medicine
03:01 - The Insurance Challenge
06:29 - Rapid Advances & The Tsunami Myth
09:12 - Fixes: Stop Loss, Risk Pools, and Annuities
Don’t forget to subscribe for more insights. Sources and further reading in the description—check out Dan’s Substack for full research references!
In a remarkable medical advancement, baby KJ Muldoon received a groundbreaking personalized medicine. This CRISPR cas9 gene therapy targets CPS1 deficiency, a rare disease. This innovative treatment offers new hope for infant health, showcasing how precision medicine can address severe genetic disorders.